Obesity, Inflammation and Oxidative Stress

Completed · Phase 3 · Has a placebo group

Conditions studied: C-reactive Protein, Inflammation, Obesity, Oxidative Stress

In brief

The purpose of this study is to determine whether or not Vitamin C (1000 mg/day) can reduce markers of inflammation, especially C-reactive protein (CRP), in obese persons with baseline CRP greater than 1 mg/dl.

Key facts

Study ID

NCT01028976

Run by

University of California, Berkeley

People needed

512

Starts

2010-01-01

Expected to finish

2012-07-01

Last updated by the study team

2015-12-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• BMI ≥ 30
• hsCRP ≥ 1 mg/L
• Age 18+
• Member of Kaiser Permanente Health Plan of Northern California

You may not qualify if…

• Smoker
• Unwilling to discontinue vitamin supplements for study duration
• Unwilling/unable to use acetaminophen in place of OTC anti-inflammatory medications
• Use of certain medications
• History of certain medical conditions

Where it is running

• Kaiser Permanente of Northern California, Division of Research — Oakland, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.